Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease

Eleonora Gatta, Tony Lefebvre, Silvana Gaetani, Marc Dos Santos, Jordan Marrocco, Anne Marie Mir, Tommaso Cassano, S. Maccari, Ferdinando Nicoletti, Jérôme Mairesse

Research output: Contribution to journalArticle

Abstract

Intracellular accumulation of hyperphosphorylated tau protein is linked to neuronal degeneration in Alzheimer's disease (AD). Mounting evidence suggests that tau phosphorylation and O-N-acetylglucosamine glycosylation (O-GlcNAcylation) are mutually exclusive post-translational modifications. O-GlcNAcylation depends on 3-5% of intracellular glucose that enters the hexosamine biosynthetic pathway. To our knowledge, the existence of an imbalance between tau phosphorylation and O-GlcNAcylation has not been reported in animal models of AD, as yet. Here, we used triple transgenic (3xTg-AD) mice at 12 months, an age at which hyperphosphorylated tau is already detected and associated with cognitive decline. In these mice, we showed that tau was hyperphosphorylated on both Ser396 and Thr205 in the hippocampus, and to a lower extent and exclusively on Thr205 in the frontal cortex. Tau O-GlcNAcylation, assessed in tau immunoprecipitates, was substantially reduced in the hippocampus of 3xTg-AD mice, with no changes in the frontal cortex or in the cerebellum. No changes in the expression of the three major enzymes involved in O-GlcNAcylation, i.e., glutamine fructose-6-phosphate amidotransferase, O-linked β-N-acetylglucosamine transferase, and O-GlcNAc hydrolase were found in the hippocampus of 3xTg-AD mice. These data demonstrate that an imbalance between tau phosphorylation and O-GlcNAcylation exists in AD mice, and strengthens the hypothesis that O-GlcNAcylation might be targeted by disease modifying drugs in AD.

Original languageEnglish
Pages (from-to)186-197
Number of pages12
JournalPharmacological Research
Volume105
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Hippocampus
Alzheimer Disease
Phosphorylation
Frontal Lobe
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
Hexosamines
tau Proteins
Acetylglucosamine
Biosynthetic Pathways
Hydrolases
Post Translational Protein Processing
Glycosylation
Cerebellum
Animal Models
Glucose
Enzymes
Pharmaceutical Preparations

Keywords

  • 3xTg-AD mice
  • hippocampus
  • O-GlcNAcylation
  • tau protein

ASJC Scopus subject areas

  • Pharmacology

Cite this

Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease. / Gatta, Eleonora; Lefebvre, Tony; Gaetani, Silvana; Dos Santos, Marc; Marrocco, Jordan; Mir, Anne Marie; Cassano, Tommaso; Maccari, S.; Nicoletti, Ferdinando; Mairesse, Jérôme.

In: Pharmacological Research, Vol. 105, 01.03.2016, p. 186-197.

Research output: Contribution to journalArticle

Gatta, E, Lefebvre, T, Gaetani, S, Dos Santos, M, Marrocco, J, Mir, AM, Cassano, T, Maccari, S, Nicoletti, F & Mairesse, J 2016, 'Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease', Pharmacological Research, vol. 105, pp. 186-197. https://doi.org/10.1016/j.phrs.2016.01.006
Gatta, Eleonora ; Lefebvre, Tony ; Gaetani, Silvana ; Dos Santos, Marc ; Marrocco, Jordan ; Mir, Anne Marie ; Cassano, Tommaso ; Maccari, S. ; Nicoletti, Ferdinando ; Mairesse, Jérôme. / Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease. In: Pharmacological Research. 2016 ; Vol. 105. pp. 186-197.
@article{516a3058306749b29d7c7b5b382019f0,
title = "Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease",
abstract = "Intracellular accumulation of hyperphosphorylated tau protein is linked to neuronal degeneration in Alzheimer's disease (AD). Mounting evidence suggests that tau phosphorylation and O-N-acetylglucosamine glycosylation (O-GlcNAcylation) are mutually exclusive post-translational modifications. O-GlcNAcylation depends on 3-5{\%} of intracellular glucose that enters the hexosamine biosynthetic pathway. To our knowledge, the existence of an imbalance between tau phosphorylation and O-GlcNAcylation has not been reported in animal models of AD, as yet. Here, we used triple transgenic (3xTg-AD) mice at 12 months, an age at which hyperphosphorylated tau is already detected and associated with cognitive decline. In these mice, we showed that tau was hyperphosphorylated on both Ser396 and Thr205 in the hippocampus, and to a lower extent and exclusively on Thr205 in the frontal cortex. Tau O-GlcNAcylation, assessed in tau immunoprecipitates, was substantially reduced in the hippocampus of 3xTg-AD mice, with no changes in the frontal cortex or in the cerebellum. No changes in the expression of the three major enzymes involved in O-GlcNAcylation, i.e., glutamine fructose-6-phosphate amidotransferase, O-linked β-N-acetylglucosamine transferase, and O-GlcNAc hydrolase were found in the hippocampus of 3xTg-AD mice. These data demonstrate that an imbalance between tau phosphorylation and O-GlcNAcylation exists in AD mice, and strengthens the hypothesis that O-GlcNAcylation might be targeted by disease modifying drugs in AD.",
keywords = "3xTg-AD mice, hippocampus, O-GlcNAcylation, tau protein",
author = "Eleonora Gatta and Tony Lefebvre and Silvana Gaetani and {Dos Santos}, Marc and Jordan Marrocco and Mir, {Anne Marie} and Tommaso Cassano and S. Maccari and Ferdinando Nicoletti and J{\'e}r{\^o}me Mairesse",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.phrs.2016.01.006",
language = "English",
volume = "105",
pages = "186--197",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press",

}

TY - JOUR

T1 - Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease

AU - Gatta, Eleonora

AU - Lefebvre, Tony

AU - Gaetani, Silvana

AU - Dos Santos, Marc

AU - Marrocco, Jordan

AU - Mir, Anne Marie

AU - Cassano, Tommaso

AU - Maccari, S.

AU - Nicoletti, Ferdinando

AU - Mairesse, Jérôme

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Intracellular accumulation of hyperphosphorylated tau protein is linked to neuronal degeneration in Alzheimer's disease (AD). Mounting evidence suggests that tau phosphorylation and O-N-acetylglucosamine glycosylation (O-GlcNAcylation) are mutually exclusive post-translational modifications. O-GlcNAcylation depends on 3-5% of intracellular glucose that enters the hexosamine biosynthetic pathway. To our knowledge, the existence of an imbalance between tau phosphorylation and O-GlcNAcylation has not been reported in animal models of AD, as yet. Here, we used triple transgenic (3xTg-AD) mice at 12 months, an age at which hyperphosphorylated tau is already detected and associated with cognitive decline. In these mice, we showed that tau was hyperphosphorylated on both Ser396 and Thr205 in the hippocampus, and to a lower extent and exclusively on Thr205 in the frontal cortex. Tau O-GlcNAcylation, assessed in tau immunoprecipitates, was substantially reduced in the hippocampus of 3xTg-AD mice, with no changes in the frontal cortex or in the cerebellum. No changes in the expression of the three major enzymes involved in O-GlcNAcylation, i.e., glutamine fructose-6-phosphate amidotransferase, O-linked β-N-acetylglucosamine transferase, and O-GlcNAc hydrolase were found in the hippocampus of 3xTg-AD mice. These data demonstrate that an imbalance between tau phosphorylation and O-GlcNAcylation exists in AD mice, and strengthens the hypothesis that O-GlcNAcylation might be targeted by disease modifying drugs in AD.

AB - Intracellular accumulation of hyperphosphorylated tau protein is linked to neuronal degeneration in Alzheimer's disease (AD). Mounting evidence suggests that tau phosphorylation and O-N-acetylglucosamine glycosylation (O-GlcNAcylation) are mutually exclusive post-translational modifications. O-GlcNAcylation depends on 3-5% of intracellular glucose that enters the hexosamine biosynthetic pathway. To our knowledge, the existence of an imbalance between tau phosphorylation and O-GlcNAcylation has not been reported in animal models of AD, as yet. Here, we used triple transgenic (3xTg-AD) mice at 12 months, an age at which hyperphosphorylated tau is already detected and associated with cognitive decline. In these mice, we showed that tau was hyperphosphorylated on both Ser396 and Thr205 in the hippocampus, and to a lower extent and exclusively on Thr205 in the frontal cortex. Tau O-GlcNAcylation, assessed in tau immunoprecipitates, was substantially reduced in the hippocampus of 3xTg-AD mice, with no changes in the frontal cortex or in the cerebellum. No changes in the expression of the three major enzymes involved in O-GlcNAcylation, i.e., glutamine fructose-6-phosphate amidotransferase, O-linked β-N-acetylglucosamine transferase, and O-GlcNAc hydrolase were found in the hippocampus of 3xTg-AD mice. These data demonstrate that an imbalance between tau phosphorylation and O-GlcNAcylation exists in AD mice, and strengthens the hypothesis that O-GlcNAcylation might be targeted by disease modifying drugs in AD.

KW - 3xTg-AD mice

KW - hippocampus

KW - O-GlcNAcylation

KW - tau protein

UR - http://www.scopus.com/inward/record.url?scp=84958034402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958034402&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2016.01.006

DO - 10.1016/j.phrs.2016.01.006

M3 - Article

VL - 105

SP - 186

EP - 197

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -